NXGL · Nexgel, Inc. · Financials
$0.29
0.00 (-1.34%)
At close · Sep 11
Going-concern doubt
— flagged Aug 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an unrestricted cash balance of $0.5 million. For the six months ended June 30, 2026, the Company incurred a net loss of $4.5 million and had a net usage of cash in operating activities of $2,701 thousand. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 17, 2026
Market Cap
$2.83M
Shares
9.75M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$11.42M
+31.5%
FY2025
Net Income
-$3M
+8.6%
FY2025
Gross Margin
39.48%
+7.8pp
FY2025
Operating Margin
-29.35%
+11.6pp
FY2025
Diluted EPS
-$0.38
+24%
FY2025
Operating Cash Flow
-$1.31M
+66.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $12.07M | $11.42M | $8.69M | $4.09M | $2.05M | $1.55M | $674K | $717K | $2.21M | |
| $7.83M | $6.91M | $5.94M | $3.72M | $1.79M | $1.54M | $965K | $854K | $1.7M | |
| $4.23M | $4.51M | $2.75M | $374K | $256K | $8000 | -$291K | -$137K | $514K | |
| — | 39.48% | 31.63% | 9.15% | 12.5% | 0.52% | -43.18% | -19.11% | 23.23% | |
| — | $2000 | $78K | $103K | $367K | $31K | — | — | — | |
| $9.61M | $7.86M | $6.22M | $3.75M | $3.24M | $2.55M | $1.97M | $1.79M | $2.4M | |
| $889K | $126K | $119K | $94K | $13K | — | — | — | — | |
| $1.15M | $450K | $436K | $226K | $112K | $113K | $50K | $67K | $322K | |
| $9.64M | $7.86M | $6.3M | $3.85M | $3.6M | $2.58M | $1.97M | $1.79M | $2.4M | |
| -$5.4M | -$3.35M | -$3.55M | -$3.48M | -$3.35M | -$2.57M | -$2.26M | -$1.92M | -$1.89M | |
| — | -29.35% | -40.91% | -85.03% | -163.48% | -165.7% | -335.31% | -268.34% | -85.31% | |
| -$4.25M | -$2.9M | -$3.12M | -$3.25M | -$3.24M | -$2.46M | -$2.21M | -$1.86M | -$1.57M | |
| — | $34K | $81K | $15K | $1.34M | — | — | — | — | |
| -$650K | $459K | $91K | $289K | -$1.4M | -$1.74M | -$4000 | $1000 | — | |
| -$6.05M | -$2.89M | -$3.46M | -$3.19M | -$4.75M | — | — | — | — | |
| — | — | — | — | $0 | $0 | $0 | $0 | — | |
| -$6.22M | -$3M | -$3.28M | -$3.16M | -$4.75M | -$4.31M | -$2.26M | -$1.92M | -$1.89M | |
| — | -26.27% | -37.76% | -77.21% | -231.74% | -277.89% | -335.91% | -268.2% | -85.31% | |
| $133K | $107K | -$182K | -$31K | — | — | — | — | — | |
| USD/shares | -$0.71 | -$0.38 | -$0.50 | -$0.56 | -$0.85 | -$1.45 | -$1.05 | -$0.14 | -$0.38 |
| USD/shares | -$0.71 | -$0.38 | -$0.50 | -$0.56 | -$0.85 | -$1.45 | -$1.05 | -$0.14 | -$0.38 |
| shares | — | 7.85M | 6.51M | 5.67M | 5.57M | 2.98M | 2.25M | 13.57M | 5.01M |
| shares | — | 7.85M | 6.51M | 5.67M | 5.57M | 2.98M | 2.25M | 13.57M | 5.01M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.11×
Medical Instruments & Supplies median 2.37×
EV/EBIT
—
Medical Instruments & Supplies median 27.93×
P/E (TTM)
—
Medical Instruments & Supplies median 28.25×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1468929
CUSIP
65344E107
13F (30d)
13 filings
13 filers
Visit website
Investor relations